1. Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors

   • Sabina Sandigursky
   • Adam Mor

   Hot Topics (B Cronstein, Section Editor) 06 September 2018 Article: 65

2. A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy

   • Peter K. K. Wong
   • Hanish Bagga
   • Laurel Young

   Rheumatoid Arthritis (L Moreland, Section Editor) 01 September 2018 Article: 64

3. Brief Report on the 10th Meeting of the European Forum on Antiphospholipid Antibodies

   • Valérie Eschwège
   • Cécile M. Yelnik
   • Denis Wahl

   Invited Commentary 21 August 2018 Article: 63

   

4. Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)

   • Claudia Mendoza-Pinto
   • Mario García-Carrasco
   • Ricard Cervera

   Antiphospholipid Syndrome (S Zuily, Section Editor) 20 August 2018 Article: 62

5. Rheumatic Manifestations of Haemoglobinopathies

   • Michael Hughes

   Orphan Diseases (B Manger, Section Editor) 14 August 2018 Article: 61

   

6. Induction Therapy for Lupus Nephritis: the Highlights

   • Isabelle Ayoub
   • Jessica Nelson
   • Brad H. Rovin

   Pediatric Rheumatology (S Ozen, Section Editor) 14 August 2018 Article: 60

   

7. Obstetric Anti-phospholipid Syndrome: State of the Art

   • Maria Chiara Gerardi
   • Melissa Alexandre Fernandes
   • Laura Andreoli

   Antiphospholipid Syndrome (S Zuily, Section Editor) 13 August 2018 Article: 59

8. The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy

   • Luis R. Espinoza

   Psoriatic Arthritis (J Scher, Section Editor) 09 August 2018 Article: 58

9. Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

   • Sizheng Zhao
   • Laura Chadwick
   • Robert J. Moots

   Biosimilars (E Mysler, Section Editor) Open access 09 August 2018 Article: 57